Quarterly Result12 Aug 2026, 05:41 pm
Mangalam Drugs declares Q1 FY27 Un-audited Financial Results
AI Summary
Mangalam Drugs & Organics Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results. The company also declared that its statutory auditors have not expressed any modified opinions in their Limited Review Reports. Additionally, the company approved the appointment of M/s L.N. Joshi & Co. as Secretarial Auditors and M/s SN. Nanda & Co. as Statutory Auditors for a term of five years, subject to shareholder approval.
Key Highlights
- Company declared un-audited financial results for Q1 FY27.
- Results were approved by the Board of Directors.
- Statutory auditors issued an unmodified Limited Review Report.
- New secretarial and statutory auditors appointed for five years.
- Appointments are subject to shareholder approval at the upcoming AGM.
Price Impact
More from MANGALAM